Health and wellness products company USANA Health Sciences (NYSE: USNA) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 5.9% year on year to $226.2 million. The company’s full-year revenue guidance of $962.5 million at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.60 per share was 46.3% above analysts’ consensus estimates.

Is now the time to buy USNA? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

USANA’s fourth quarter results met Wall Street’s expectations on revenue and surpassed estimates for non-GAAP profit, yet the market responded negatively. Management attributed this to ongoing margin pressures and a continued shift in business mix, particularly the growing role of lower-margin brands like Rise Wellness and Hiya. CEO Kevin Guest, who resumed his leadership role, highlighted operational changes and a strategic pivot toward omnichannel distribution and scientific product innovation. He acknowledged headwinds, saying, “Our core business has faced year-over-year sales declines, but we are seeing encouraging signs of stabilization.”

Looking ahead, USANA’s guidance reflects optimism about its expanding omnichannel strategy and new product initiatives, especially for Hiya and Rise Wellness. Management emphasized the importance of technology upgrades and leveraging AI to personalize customer experiences. Guest outlined the company’s focus: “We have to play in [AI] and be as good at technology and utilizing AI as we are in Nutrition.” The leadership team also noted that execution in retail partnerships and international markets will be critical, as will disciplined cost management, to capture emerging growth opportunities and support long-term profitability.

Key Insights from Management’s Remarks

USANA’s fourth quarter call emphasized a strategic evolution, with management focusing on omnichannel growth, operational discipline, and new product expansion as primary levers for future performance.

• Leadership transition: Kevin Guest’s return as CEO signals a renewed focus on stability and executing long-term growth strategies, drawing on his deep experience and prior expansion of USANA’s international and operational footprint.
• Omnichannel expansion: Management is prioritizing the shift from a legacy direct selling model to a broader omnichannel approach, aiming to capture a wider base of health-conscious consumers through retail partners like Target and Costco.
• Brand portfolio diversification: The company’s investments in brands like Rise Wellness and Hiya are designed to offset slowing core nutrition sales, with these brands driving inventory build-up and opening new retail and international channels.
• Operational cost discipline: USANA implemented a workforce reduction of about 10%, redirecting savings toward technology and market expansion initiatives, while acknowledging that gross margin will face ongoing pressure due to business mix changes.
• Technology and AI focus: Leadership highlighted plans to accelerate technology modernization, including leveraging external platforms and AI to improve customer engagement and support scalable growth, viewing this as essential to maintaining relevance and driving future performance.

Drivers of Future Performance

USANA’s outlook for the coming year centers on scaling new brands, broadening retail partnerships, and investing in technology to support growth, while managing margin headwinds.

• Retail and international channel growth: Management expects Hiya and Rise Wellness to fuel revenue, with both brands expanding into major U.S. retailers and new countries. These efforts are seen as critical for reducing reliance on core nutrition sales and improving revenue diversification.
• Margin pressure from business mix: The company acknowledged that a higher contribution from lower-margin brands, particularly Rise Wellness, will weigh on overall gross margins, even as cost-saving measures and manufacturing efficiencies are pursued.
• Technology modernization and AI adoption: Planned investments in technology and AI will aim to enhance customer personalization and operational agility. However, leadership cautioned that the full impact of these projects on profitability and customer retention will depend on successful execution and may take time to materialize.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will watch (1) the pace of retail distribution and international expansion for Hiya and Rise Wellness, (2) whether technology upgrades and AI initiatives translate into improved customer engagement and operational efficiency, and (3) the company’s ability to stabilize gross margins despite a shifting business mix. Sustained momentum in omnichannel partnerships will also be a key metric of success.

USANA currently trades at $18.99, down from $20.67 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

Stocks That Trumped Tariffs

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.